NCT03149744View on ClinicalTrials.gov

Mixed Methods Evaluation of a Novel Apnoea Event Detection Monitor

CompletedOBSERVATIONAL
Enrollment

127

Participants

Timeline

Start Date

February 28, 2017

Primary Completion Date

May 2, 2017

Study Completion Date

May 2, 2017

Conditions
Respiratory Rate
Interventions
DEVICE

RespiraSense Sleep Screener

RespiraSense will be worn at the same time as the standard of care SomnoScreen and it's results will be masked to the site team

Trial Locations (1)

PO6 3LY

Queen Alexandra Hospital, Portsmouth

Sponsors

Lead Sponsor

PMD Solutions
All Listed Sponsors
lead

PMD Solutions

INDUSTRY

collaborator

Portsmouth Hospitals NHS Trust

OTHER_GOV

NCT03149744 - Mixed Methods Evaluation of a Novel Apnoea Event Detection Monitor | Biotech Hunter | Biotech Hunter